High Tower Advisors, LLC Adaptive Biotechnologies Corp Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 16,683 shares of ADPT stock, worth $78,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,683

Previous 16,683 -0.0%

Holding current value

$78,243

Previous $60,000 41.67%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.34 - $3.96 $2,585 - $4,375	1,105 Added 7.09%	16,683 $60,000
Q1 2024 May 06, 2024	SELL	$2.88 - $4.8 $2,306 - $3,844	-801 Reduced 4.89%	15,578 $50,000
Q4 2023 Feb 12, 2024	BUY	$3.46 - $5.33 $2,771 - $4,269	801 Added 5.14%	16,379 $80,000
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $40,854 - $57,947	-6,600 Reduced 29.76%	15,578 $104,000
Q1 2023 May 11, 2023	SELL	$7.8 - $10.11 $43,095 - $55,857	-5,525 Reduced 19.94%	22,178 $195,000
Q3 2022 Nov 09, 2022	SELL	$6.5 - $12.67 $734 - $1,431	-113 Reduced 0.41%	27,703 $197,000
Q2 2022 Aug 10, 2022	BUY	$6.4 - $14.73 $105,081 - $241,851	16,419 Added 144.06%	27,816 $226,000
Q1 2022 May 12, 2022	BUY	$10.12 - $28.9 $115,337 - $329,373	11,397 New	11,397 $160,000
Q4 2021 Feb 10, 2022	SELL	$25.17 - $36.85 $309,867 - $453,660	-12,311 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $56,707 - $75,314	-1,889 Reduced 13.3%	12,311 $418,000
Q2 2021 Aug 06, 2021	SELL	$32.22 - $44.59 $47,363 - $65,547	-1,470 Reduced 9.38%	14,200 $580,000
Q1 2021 May 10, 2021	SELL	$37.26 - $67.74 $485,944 - $883,465	-13,042 Reduced 45.42%	15,670 $631,000
Q4 2020 Feb 10, 2021	BUY	$45.01 - $65.47 $360,620 - $524,545	8,012 Added 38.71%	28,712 $1.7 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $277,372 - $378,277	7,750 Added 59.85%	20,700 $1.01 Million
Q2 2020 Aug 10, 2020	SELL	$24.95 - $48.38 $355,537 - $689,415	-14,250 Reduced 52.39%	12,950 $627,000
Q1 2020 May 21, 2020	SELL	$16.96 - $34.16 $511,768 - $1.03 Million	-30,175 Reduced 52.59%	27,200 $756,000
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $1.41 Million - $1.88 Million	57,375 New	57,375 $1.72 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Adaptive Biotechnologies Corp Transaction History